Eli Lilly stock dips on Novo Nordisk's rival drug data
-- Shares of pharmaceutical giant Eli Lilly (NYSE:LLY) edged down 1.2% in premarket trading following announcements from competitor Novo Nordisk (NYSE:NVO) regarding...
-- Shares of pharmaceutical giant Eli Lilly (NYSE:LLY) edged down 1.2% in premarket trading following announcements from competitor Novo Nordisk (NYSE:NVO) regarding...
-- Bank of America analysts expect Apple (NASDAQ:AAPL) to report strong fiscal Q1 2025 results on January 30, driven by robust initial demand for the iPhone...
-- American Express Company reported fourth-quarter earnings that surpassed analyst expectations, but shares slipped 1.1% following the announcement. The financial...
- American Express (NYSE: AXP) reported fourth quarter EPS of $3.04, $0.02 better than the analyst estimate of $3.02. Revenue for the quarter came in at $17.18B...
-- Verizon (NYSE:VZ) on Friday reported better-than-expected earnings and revenue for the fiscal fourth quarter. The company's shares rose more than 1% in premarket...
- Verizon (NYSE: VZ) reported fourth quarter EPS of $1.10, $0.01 better than the analyst estimate of $1.09. Revenue for the quarter came in at $35.7B versus the...
-- Bank of America strategists project a decline in Europe’s Stoxx 600 of approximately 10% from its current highs by mid-year, noting that the cyclicals in the...
-- Larry Fink, the CEO of BlackRock (NYSE:BLK), has suggested that it might be time to reinvest in Europe, citing an overabundance of pessimism about the region. His...
-- European equities are off to their second-best start in 15 years, driven by gains in mega caps and cyclicals, according to Barclays (LON:BARC) analysts. Stocks...
-- According to Fitch Ratings, the world's leading reinsurers are expected to weather the financial impact from their exposure to the Los Angeles fires without...